Author

Sheng Wang

Johns Hopkins School of Medicine - Cited by 3,153 - Pancreatic cancer - radiation oncology - rectal cancer

Biography

Sheng Wang  was working as China State Institute of Pharmaceutical Industry, Shanghai, China . SHe is the Editorial Board Member of many peer reviewed journals and area of expertise, as an Research Scholar credits with many publications in national and international journals.  and committed to highest standards of excellence and it proves through his/her co-authorship of many books.
Title
Cited by
Year
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma
J Wang, MT Saung, K Li, J Fu, K Fujiwara, N Niu, S Muth, J Wang, Y Xu, ...Journal of Experimental Medicine 219 (5), e20211631, 2022202
13
2022
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
K Li, JA Tandurella, J Gai, Q Zhu, SJ Lim, DL Thomas, T Xia, G Mo, ...Cancer cell 40 (11), 1374-1391. e7, 2022202
10
2022
Neoadjuvant stereotactic body radiotherapy after upfront chemotherapy improves pathologic outcomes compared with chemotherapy alone for patients with borderline resectable or …
CS Hill, LM Rosati, C Hu, W Fu, S Sehgal, A Hacker-Prietz, CL Wolfgang, ...Annals of surgical oncology 29 (4), 2456-2468, 2022202
10
2022
Risk of pancreatic cancer in the long-term prospective follow-up of familial pancreatic cancer kindreds
N Porter, D Laheru, B Lau, J He, L Zheng, A Narang, NJ Roberts, ...JNCI: Journal of the National Cancer Institute 114 (12), 161-16, 2022202
8
2022
High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with …
C Hill, S Sehgal, W Fu, C Hu, A Reddy, E Thompson, A Hacker‐Prietz, ...Cancer medicine 11 (7), 1659-166, 2022202
8
2022
Finite element-based personalized simulation of duodenal hydrogel spacer: Spacer location dependent duodenal sparing and a decision support system for spacer-enabled pancreatic …
H Hooshangnejad, S Youssefian, A Narang, EJ Shin, AD Rao, S Han-Oh, ...Frontiers in Oncology 12, 833231, 2022202
7
2022
Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma.
TR Heumann, C Judkins, SJ Lim, H Wang, R Parkinson, J Gai, B Celiker, ...Journal of Clinical Oncology 40 (4_suppl), 558-558, 2022202
6
2022
Accurate nodal staging in pancreatic cancer in the era of neoadjuvant therapy
AA Javed, D Ding, E Baig, MJ Wright, JA Teinor, D Mansoor, E Thompson, ...World journal of surgery, 1-11, 2022202
5
2022
Location, location, location: what should be targeted beyond gross disease for localized pancreatic ductal adenocarcinoma? Proposal of a standardized clinical tumor volume for …
CS Hill, W Fu, C Hu, S Sehgal, AV Reddy, J He, JM Herman, JJ Meyer, ...Practical Radiation Oncology 12 (3), 21-22, 2022202
5
2022
High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally …
AV Reddy, CS Hill, S Sehgal, J He, L Zheng, JM Herman, J Meyer, ...Journal of Gastrointestinal Oncology 13 (1), 368, 2022202
5
2022
Demonstrating the benefits of corrective intraoperative feedback in improving the quality of duodenal hydrogel spacer placement
H Hooshangnejad, S Han‐Oh, EJ Shin, A Narang, AD Rao, J Lee, ...Medical physics 9 (7), 79-803, 2022202
4
2022
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body …
AV Reddy, CS Hill, S Sehgal, L Zheng, J He, DA Laheru, ...Radiation Oncology Journal 0 (2), 111, 2022202
4
2022
Establishing a Deaf and American Sign Language inclusive residency program
C Hill, C Deville, A Kiess, A Narang, T Ratnanather, J Bienstock, ...Academic Medicine 97 (3), 357-363, 2022202
4
2022
Multiagent chemotherapy and stereotactic body radiation therapy in patients with unresectable pancreatic adenocarcinoma: a prospective nonrandomized controlled trial
CS Hill, L Rosati, H Wang, HL Tsai, J He, A Hacker-Prietz, DA Laheru, ...Practical Radiation Oncology 12 (6), 511-523, 2022202
4
2022
Efficacy and safety of reirradiation with stereotactic body radiation therapy for locally recurrent pancreatic adenocarcinoma
AV Reddy, CS Hill, S Sehgal, J He, L Zheng, JM Herman, J Meyer, ...Clinical Oncology 34 (6), 386-394, 0
2
2022
A safety study of intraoperative radiation therapy following stereotactic body radiation therapy and multi-agent chemotherapy in the treatment of localized pancreatic …
AV Reddy, CS Hill, L Zheng, J He, AK NarangRadiation Oncology 17 (1), 173, 0
2
2022
Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy
GD Ivey, S Shoucair, DJ Delitto, JR Habib, B Kinny-Köster, CR Shubert, ...World journal of surgery 46 (11), 751-759, 0
2
2022
Multiagent chemotherapy followed by stereotactic body radiotherapy versus conventional radiotherapy for resected pancreas cancer
M Mokhtech, JA Miccio, K Johung, M Cecchini, S Stein, AK Narang, ...American Journal of Clinical Oncology 45 (11), 450-457, 0
2
2022
A liquid immunogenic fiducial eluter for image-guided radiotherapy
M Moreau, G Richards, S Yasmin-Karim, A Narang, C Deville Jr, W NgwaFrontiers in Oncology 1, 100088, 0
2
2022
The timing of surgery following stereotactic body radiation therapy impacts local control for borderline resectable or locally advanced pancreatic cancer
T Lin, A Reddy, C Hill, S Sehgal, J He, L Zheng, J Herman, J Meyer, ...Cancers 5 (4), 252, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=TJxDcyIAAAAJ&hl=en

Cited by
Citations 3153
h-index 23
i10-index 44
Recommended Journals
Open Access Journals